IEEE Engineering Medicine and Biology Society’s Post

Do you have experience working on AI/ML projects in LMICs? Your insights could be key in understanding the state of AI infrastructure across these regions. In just 5 minutes, share your thoughts on the availability, affordability, and reliability of AI resources. Help us build a clearer picture of the challenges and opportunities faced by AI practitioners in LMICs. ⏳The survey is open for a week and is confidential and GDPR-compliant, ensuring your data privacy. Take the survey here 👉  https://buff.ly/3O3ZAY3

📽️ We've just posted our first speaker from the XAIB24 Conference in October: Professor Tim Hubbard provides a detailed look at the complexities of managing sensitive biological data, the role of AI in advancing research, and the need for secure, interoperable systems to handle these large datasets while maintaining privacy and compliance. He also explores some of the challenges and opportunities in managing biological and health data within Trusted Research Environments (TREs) and the evolving infrastructure supporting these efforts. ✨ Watch the full talk on our YouTube channel! #AI #FutureofAI #AIinMedicine #AIinBiology

The U.S. AI Safety Institute, within the National Institute of Standards and Technology (NIST), has released the second public draft of its "Managing Misuse Risk for Dual-Use Foundation Models" guidelines. Read full story: https://lnkd.in/eVnNEBG9 --- #GovConNews #AIStandards #TechRegulations

The EU AI Act was celebrated by regulatory bodies. I must say, the first draft was pretty bad. Here we discuss the issues in its development and the lack of actual technical experts in the conversation. - With Dr. Paul Springer Listen to the full episode here: https://lnkd.in/dVvCeyKK #AI4Good #MI4People #AIAct

With great power comes great responsibility - and this has never been more true than with AI. Here's our three 'must-haves' to mitigate risk with AI in research: 🔏 Control data privacy 🔁 Traceability and reproducibility 📝 Context availability Curious about AI but scared about the risks? Hear what @Labmanager had to say, and learn more 👇 https://bit.ly/4bvujGB

I am looking forward to meeting fellow data enthusiasts/ leaders and diving into the topic of AI enablement in life sciences organizations. This area presents exciting opportunities and challenges, from ensuring data privacy and security to integrating AI solutions with existing systems. Key points for discussion include addressing biases in AI models, maintaining data quality, navigating regulatory hurdles, and considering the ethical implications of AI in patient care and research. Excited to share insights and explore these critical topics together #dreamforce2024 #ConexusDataServicesandInsights #TheTeamBehindYourTeam

📢 𝗡𝗲𝘄𝘀𝗳𝗹𝗮𝘀𝗵: 𝗧𝗵𝗲 𝗔𝗜 𝗔𝗰𝘁 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 The groundbreaking AI Act has been published in the Official Journal of the European Union and will enter into force on 1 August 2024. It foresees a phased application with different obligations becoming applicable at different points in time. Read our latest news here! #EY #Belgium #AIAct #ArtificialIntelligenceAct #ArtificialIntelligence

Catch an inside look at Session 300: "Artificial Intelligence and How NPs Can Use It as an Advantage." This insightful session explored the integration of AI into clinical practice, showcasing benefits like enhanced efficiency, streamlined documentation, and potential cost reductions. We also tackled ethical considerations, data privacy concerns, and the training required for effective AI use. NPs are uniquely positioned to leverage AI technologies responsibly while maintaining a focus on patient-centered care. If you missed it, you can still view the recorded session until January 25, 2025! #NCNPConf #ArtificialIntelligence #APRNs #NursePractitioners https://ow.ly/VyBn50TTwM2

Check out the key takeaways from the recent agreement between the Texas AG's office and a GenAI healthcare technology company. Many thanks to Texas Lawyer for publishing the article from me and Graham Ryan!